product1 publisher
Novo is piloting Claude Science on drug discovery problems its own scientists named
The Danish drugmaker will test Anthropic's science workbench on specific R&D workflows while an earlier company-wide OpenAI agreement keeps running alongside it. Bloomberg reported that financial terms were not disclosed.
Publishers:thenextweb.com
Reality
- Evidence52
- Adoption22
- Hype gap+45
- Incentives82
- Confidence58